Drug Search Results
More Filters [+]

Diclofenac

Alternative Names: diclofenac, voltaren, voltarol, diclophenac, pennsaid, cataflam, solaraze, dicrofenac, voltaren ophtha, flector, zipsor, HP-5000, hp5000, amz-001, amz001, si-613, si 613, si613, epoladerm, zorvolex, DICHLOPHENAC, DICLOFENACO, dicloflex, licart, dyloject, aspercreme arthritis, salonpas, biifenac 500, biifenac 1000, cambia, arthrotec, dfs 1.5%/ms 25%/menth 6%/cap 0.025% pak, dfs 75mg dr/ms 25%/menth 6%/cap 0.025% pak, pennsaicin, arthritis pain reliever, varophen, iclofenac cp, lofena, dicloheal-60, capsfenac pak, ziclopro, valcoprep-100, nudiclo solupak, diclovix, nudiclo tabpak, nudroxipak dsdr-50, nudroxipak dsdr-75, inavix, diclovix m, OSF-200, OSF200, OSF 200
Latest Update: 2024-06-10
Latest Update Note: News Article

Product Description

Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild-to-moderate pain, and helps to relieve symptoms of arthritis (eg, osteoarthritis or rheumatoid arthritis), such as inflammation, swelling, stiffness, and joint pain. This medicine does not cure arthritis and will only help you as long as you continue to take it. (Sourced from: https://www.mayoclinic.org/drugs-supplements/diclofenac-oral-route/description/drg-20069748)

Mechanisms of Action: COX2 Inhibitor,COX1 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Transdermal,Topical

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Acute Pain | Pain Unspecified | Arthritis | Osteoarthritis | Acute Pain | Pain Unspecified | Contusions | Pain Unspecified | Duodenal Ulcer | Arthritis, Rheumatoid | Arthritis | Osteoarthritis

Known Adverse Events: Hypertension | Abdominal Pain | Dizziness | Headache | Pain Unspecified | Pruritus | Sinusitis | Constipation | Diarrhea | Dyspepsia | Edema | Flatulence | Insomnia | Gastritis

Company: Novartis
Company Location: BASEL V8 CH 4056
Company CEO: Vasant Narasimhan
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Diclofenac

Countries in Clinic: Australia, China, Japan, United States

Active Clinical Trial Count: 29

Highest Development Phases

Phase 3: Acute Pain|Cancer Pain|Chronic Pain|Injuries/wounds Unspecified|Keratosis, Actinic|Low Back Pain|Osteoarthritis, Knee|Pain Unspecified

Phase 2: Healthy Volunteers|Musculoskeletal Pain

Phase 1: Arthritis, Rheumatoid|Bursitis|Headache|Myalgia|Osteoarthritis|Rheumatic Fever|Shoulder Pain|Tenosynovitis|Toothache

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

KP-01-2024

P2

Not yet recruiting

Osteoarthritis, Knee

2024-12-31

24%

ACTRN12624000341527

P1

Not yet recruiting

Osteoarthritis, Knee

2024-07-14

BF-01-2023

P1

Recruiting

Pain Unspecified

2024-06-30

43%

18US-FHp04

P3

Recruiting

Injuries/wounds Unspecified|Pain Unspecified

2024-06-15

95%

Recent News Events